| 摘要 |
<p>New ligands for the ORL-1 receptor are described, useful for modulating the activity of said receptors in a patient in need thereof, and for preventing and treating illnesses dependent on the stimulation of this receptor. The new compounds conform to structural formula (I)
wherein R1, R2, R3, R4 are further defined in the description.</p> |
